We provide investors access to unique investment opportunities that deliver superior risk-adjusted returns in today's challenging markets. Our investments provide growth capital and infrastructure, resulting in a broader progressive impact within Asia.
This fund seeks to invest in 25-30 companies through the life of its 8-year fund at the pre-series A and series A stages. The fund will invest in early-stage businesses in India, typically in pre-series A or series A rounds.
The Fund seeks to empower early and growth stage companies in India and South East Asia, providing them capital to scale without significantly diluting equity. The region's venture debt market has the potential to scale up by 4-5x over the next few years.
Following the successful closure of LC Nueva Fund at USD 42 Mn in 2023, the LC Nueva Momentum Fund has been launched as a follow up Fund. This Fund will leverage existing portfolio relationships to explore adjacent opportunities and capitalize on secondaries to invest in promising new ventures. While majority of the capital will be allocated to winners, adjacent opportunities, and secondaries, The Fund will also seek out new opportunistic investments.
Providing high-yield direct lending and special situations credit opportunities to mid-market companies across the APAC region. The fund captures the entire spectrum of credit opportunities, including performing credit, structured credit, asset-backed lending, dislocated credit, high yield bonds, and event-driven situations. The objective is to generate competitive risk-adjusted returns by addressing the significant financing gap in Asia's underserved private credit market.
LC Luminere Credit Fund is a sector-agnostic, closed-ended performing credit fund structured as a Category II SEBI-registered AIF, designed to make senior secured investments in high quality sponsor backed mid-market corporates in India.
Providing short-term financing facilities to mid-market corporate entities, Small-to-Medium Enterprises and other corporates that expect to earn significant revenue from developed markets.
In partnership with La Caisse this SPV invests in life sciences real estate and owns the largest life sciences R&D real estate portfolio in India.
